• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2014 Fiscal Year Final Research Report

Gene therapy for head and neck cancer using replication-selective adenoviral vector

Research Project

  • PDF
Project/Area Number 25670717
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Otorhinolaryngology
Research InstitutionKobe University

Principal Investigator

KEN-ICHI Nibu  神戸大学, 医学(系)研究科(研究院), 教授 (20251283)

Co-Investigator(Kenkyū-buntansha) OTSUKI Naoki  神戸大学, 大学院医学研究科, 准教授 (40343264)
Co-Investigator(Renkei-kenkyūsha) SHIRAKAWA Toshirou  神戸大学, 大学院保健学研究科, 准教授 (70335446)
Project Period (FY) 2013-04-01 – 2015-03-31
Keywordsgene therapy / head and neck cancer / adenoviral vector / replication-selective / siRNA / VEGF / Midkine
Outline of Final Research Achievements

A conditional replication-selective adenovirus vector in which the expression of E1a and E1b, required for viral replication, are controlled by the Midkine promoter, Ad-MK-E1, was generated.
To further enhance the oncolytic activity of Ad-MK-E1a, we integrated gene-expressing siRNA against VEGF to Ad-MK-E1 and generated Ad-MK-siVEGF. In vitro assays showed significant growth suppression not only in the cell lines expressing strong Midkine but also in the cell lines expressing weak Midkine, in comparison with adenoviral vector containing LacZ.

Free Research Field

耳鼻咽喉科頭頸部外科

URL: 

Published: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi